David C. Hodgson
Director · Royalty Pharma plc
Individual
- 2024
- Jun 8, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David C. Hodgson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- Dawn Christine Maroney - $9.99M in ALHC purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David C. Hodgson?
David C. Hodgson is a corporate insider, tracked as Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David C. Hodgson last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 6 filings going back to 2024.
